LIFECORE BIOMEDICAL, INC. \DE\ — Director's Dealing 2020

Oct 20, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LANDEC CORP \CA\ (LNDC)
CIK: 0001005286
Period of Report: 2020-10-19

Reporting Person: McLaughlin Brian F (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-10-19	Common Stock	M	5000	$10.09	Acquired	19532	Direct
2020-10-19	Common Stock	F	2479	$10.09	Disposed	17053	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-10-19	Restricted Stock Unit	$	M	5000	Disposed	2020-10-19	Common Stock (5000)	Direct

Footnotes

F1: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis.

F2: The restricted stock units were granted on October 19, 2017.

F3: The restricted stock units vested on October 19, 2020.